Finasteride boosts PSA ability to detect prostate cancer

August 22, 2006

The medication finasteride, which after the seven-year Prostate Cancer Prevention Trial (PCPT) was associated with a 24.8 percent reduction of prostate cancer risk among men who took it, has a new feather in its cap – it beefs up the diagnostic power of the prostate-specific antigen (PSA) test.






New report: Age, race, diet have effect on PSA levels over time

December 13, 2005

A man’s age, race and diet have a significant impact on how much his prostate-specific antigen (PSA) concentration changes over time, according to a report released Dec. 12 by researchers from institutions including the Health Science Center and the Cancer Therapy and Research Center (CTRC).